| Kjell N Lindgren, MD | |
|
301 University Blvd, Galveston, TX 77555-5302 | |
| (409) 772-5845 | |
| Not Available |
| Full Name | Kjell N Lindgren |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 301 University Blvd, Galveston, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336191212 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 47037 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kjell N Lindgren, MD 2612 White Ibis Ct, League City, TX 77573-7750 Ph: (281) 576-9562 | Kjell N Lindgren, MD 301 University Blvd, Galveston, TX 77555-5302 Ph: (409) 772-5845 |
News Archive
Immunology researchers at UT Southwestern Medical Center have found that bacteria present in the human gut help initiate the body's defense mechanisms against Toxoplasma gondii, the parasite responsible for toxoplasmosis.
August is National Breastfeeding Awareness Month, and Kaiser Permanente believes that one of the most important choices a mother can make to promote the health of her family is to choose to breastfeed exclusively. Kaiser Permanente, with more than 90,000 births in 2009, uses its integrated care delivery model to help mothers understand the benefits of breastfeeding to both mother and child and support the mother's infant feeding decision.
A new study by French researchers links ultra-processed food consumption and cancer. Ultra-processed foods include mass produced chicken and fish nuggets, meatballs, breads, buns, crisps, chocolates, sweets, cakes, instant noodles and soups, frozen and ready to eat meals, sodas, sweetened drinks etc.
Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, today announced four studies of bavituximab and its other PS-targeting antibodies have been accepted for presentation at the 101st Annual Meeting of the American Association for Cancer Research to be held April 17-21, 2010 in Washington, D.C.
Protalix BioTherapeutics, Inc. (NYSE-Amex:PLX), announced today that it has received notice from the U.S. Food and Drug Administration (FDA) that the FDA's Office of Orphan Products Development has granted orphan drug designation to prGCD, the Company's proprietary plant cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease.
› Verified 7 days ago
Timothy David Brock, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, University Of Texas Medical Branch, Galveston, TX 77555 Phone: 409-772-7118 Fax: 409-772-9068 | |
Samantha King, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-747-6131 | |
Dr. Richard Wayne Cole, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 281-483-7999 | |
Christine Marie Houser, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 | |
Dr. William Edward Powers, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-747-6131 | |
Edward Zompa, M.D., PH.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2027 61st St, Galveston, TX 77551 Phone: 409-744-9800 |